ACE and Alport syndrome: A growing body of literature suggests that timely initiation of angiotensin-converting enzyme inhibitor treatment may slow the progression of kidney disease in patients with Alport syndrome further supporting the need for early diagnosis and early nephroprotective therapy in oligosymptomatic patients [11].